Tang Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Tang Capital Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-237,694	Closed	-$3.57M	–	135
2023 Q3	$3.57M	Buy	237,694 +96,685	+69%	+$1.77M	0.5%	53
2023 Q2	$4.12M	Sell	141,009 -4,654	-3%	-$144K	0.61%	48
2023 Q1	$3.36M	Buy	145,663 +11,540	+9%	+$312K	0.5%	51
2022 Q4	$1.93M	Sell	134,123 -7,250	-5%	-$140K	0.28%	60
2022 Q3	$3.39M	Buy	141,373 +2,500	+2%	+$64.5K	0.42%	53
2022 Q2	$2.75M	Buy	138,873 +56,720	+69%	+$1.26M	0.42%	47
2022 Q1	$2.96M	Buy	82,153 +30,780	+60%	+$1.14M	0.59%	37
2021 Q4	$2.3M	Buy	51,373 +26,990	+111%	+$1.62M	0.46%	26
2021 Q3	$1.74M	Buy	+24,383	New	+$2.77M	0.36%	20

Other funds holding ASLN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $645M AUM 27.59% 1-Year Est. Return

Tang Capital Management's ASLN Position: Q4 2023 in Review

Tang Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2023, closing a stake of 237,694 shares — an estimated $3.57M sold.

Tang Capital Management first reported a position in ASLN in Q3 2021 and held it in 9 quarters. The position peaked at $4.12M in Q2 2023. 22 funds tracked by Wall St. Rank hold ASLN as of Q4 2023.

Tang Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Tang Capital Management sold 237,694 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2023, an estimated $3.57M.
Tang Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 9 quarters.
Tang Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $4.12M in Q2 2023.
22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2023.

Based on Tang Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.